1. Home
  2. TENX vs ELLO Comparison

TENX vs ELLO Comparison

Compare TENX & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$13.50

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

ELLO

Ellomay Capital Ltd (Israel)

HOLD

Current Price

$18.50

Market Cap

337.7M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
ELLO
Founded
1967
1987
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
337.7M
IPO Year
2001
1998

Fundamental Metrics

Financial Performance
Metric
TENX
ELLO
Price
$13.50
$18.50
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
1.2M
7.1K
Earning Date
05-15-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.67
$15.40
52 Week High
$18.38
$30.34

Technical Indicators

Market Signals
Indicator
TENX
ELLO
Relative Strength Index (RSI) 64.01 27.75
Support Level $13.16 $16.94
Resistance Level $14.15 $19.66
Average True Range (ATR) 0.81 0.80
MACD 0.31 -0.21
Stochastic Oscillator 91.71 0.23

Price Performance

Historical Comparison
TENX
ELLO

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About ELLO Ellomay Capital Ltd (Israel)

Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.

Share on Social Networks: